Replacement of air with fluid, inflammatory. cells or cellular debris. Parenchymal, Interstitial (Restrictive) and Vascular Diseases.

Similar documents
Parenchymal, Interstitial i (Restrictive) i and Vascular Diseases

Restrictive lung diseases

Lung diseases of Vascular Origin. By: Shefaa Qa qqa

HYPERSENSITIVITY PNEUMONITIS

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

Bronkhorst colloquium Interstitiële longziekten. Katrien Grünberg, klinisch patholoog

Liebow and Carrington's original classification of IIP

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

ACUTE RESPIRATORY DISTRESS SYNDROME

SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012

Case 4 History. 58 yo man presented with prox IP joint swelling 2 months later pain and swelling in multiple joints Chest radiograph: bi-basilar

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

Usual Interstitial pneumonia and Nonspecific Interstitial Pneumonia. Nitra and the Gangs.

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

CLEARING THE AIR ON DIFFUSE PARENCHYMAL (INTERSTITIAL) LUNG DISEASE (ILD)

Histopathology: pulmonary pathology

I don t need you. Disclosure Statement. Pathology Approach to ILD 11/5/2016. Kirk D. Jones, MD UCSF Dept of Pathology

New lung lesion in a 55 year-old male treated with chemoradiation for non-small cell lung carcinoma

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

THE ACUTE RESPIRATORY DISTRESS SYNDROME. Daniel Brockman, DO

Restrictive Pulmonary Diseases

Vascular Lung Diseases

Non-neoplastic Lung Disease II

Differential diagnosis

Chest imaging II. Interstitial lung diseases

Respiratory Pathology. Kristine Krafts, M.D.

Pulmonary Pathology II. William Bligh-Glover M.D. Department of Anatomy, CWRU

PULMONARY PATHOLOGY FOR FORENSIC PATHOLOGISTS. David Moffat Pathology Update 2019

Acute Respiratory Distress Syndrome (ARDS) An Update

Manish Powari Regional Training Day 10/12/2014

Pathologic Assessment of Interstitial Lung Disease

Challenges in the Diagnosis of Interstitial Lung Disease

Lecture Notes. Chapter 16: Bacterial Pneumonia

Epidemiology and classification of smoking related interstitial lung diseases

Systemic lupus erythematosus (SLE): Pleuropulmonary Manifestations

Interstitial Lung Diseases(ILD) By : Dr. Shaher M. Samrah Done by : Ibrahim M. sun

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

Unit II Problem 2 Pathology: Pneumonia

Acute and Chronic Lung Disease

HRCT in Diffuse Interstitial Lung Disease Steps in High Resolution CT Diagnosis. Where are the lymphatics? Anatomic distribution

Challenges in the Diagnosis of Interstitial Lung Disease

International consensus statement on idiopathic pulmonary fibrosis

Katerina M. Antoniou, MD, PhD As. Professor in Thoracic Medicine ERS ILD Group Secretary Medical School, University of Crete Prague, June 2014

I have no relevant conflicts of interest to disclose

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

Bronchoalveolar Lavage and Histopathologic Diagnosis Based on Biopsy

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

The Respiratory System

The crazy-paving pattern: A radiological-pathological correlated and illustrated overview

(JPC ) Caprine lungs

Resident Case Review CHEST. Daria Manos CAR 2016

Radiologic findings of drug-induced lung disease

Unpaid scientific collaborator & advisor with Veracyte, Inc.

Chronic Interstitial (Restrictive) Lung Disease

DISEASES OF THE RESPIRATORY SYSTEM LECTURE 5 DR HEYAM AWAD FRCPATH

Hypersensitivity Pneumonitis: Epidemiology and Classification

A Review of Interstitial Lung Diseases

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

Alveolar condensation syndrome

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

ARDS - a must know. Page 1 of 14

Case of the Day Chest

Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

Dr.kassim.m.sultan F.R.C.P

How to identify interstitial pneumonias.

Daria Manos RSNA 2016 RC tment-sites/radiology/contact/faculty/dariamanos.html

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

INDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques,

Careful histopathological evaluation has shown the traditionally clinical diagnosis of

A 72-year-old male with worsening interstitial infiltrates and respiratory failure

HYPEREMIA AND CONGESTION

Histopathologic Approach to Interstitial Lung Disease

Definition, classification and epidemiology

Imaging Small Airways Diseases: Not Just Air trapping. Eric J. Stern MD University of Washington

TB Radiology for Nurses Garold O. Minns, MD

Key Difference - Pleural Effusion vs Pneumonia

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

DISEASES OF THE RESPIRATORY SYSTEM 2018 DR HEYAM AWAD LECTURE 3: CHRONIC BRNCHITIS AND BRONCHIECTASIS

DISEASES OF THE RESPIRATORY SYSTEM 2017 DR HEYAM AWAD LECTURE 5: restrictive lung diseases, part 1: fibrosing lung diseases

Myocardial Infarction

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Vasculitis local: systemic

Pulmonary Vascular Disease in Systemic Lupus Erythematosus

Restrictive Lung Diseases

* * APPROACH TO NON- NEOPLASTIC LUNG DISEASE IN TRANSBRONCHIAL AND SURGICAL BIOPSIES. Financial Disclosures: NONE. BIOPSY TECHNIQUES Bronchoscopic

Pathology of Pneumonia

Radiological syndroms. Alveolar syndrome Bronchial syndrome Interstitial syndrome Vascular syndrome Mediastinal Syndrome

Lung CT: Part 2, The Interstitial Pneumonias Clinical, Histologic, and CT Manifestations

How to Analyse Difficult Chest CT

SCLERODERMA LUNG DISEASE: WHAT THE PATIENT SHOULD KNOW

Case 1 : Question. 1.1 What is the intralobular distribution? 1. Centrilobular 2. Perilymphatic 3. Random

Radiation Pneumonitis Joseph Junewick, MD FACR

An Introduction to Radiology for TB Nurses

HEMODYNAMIC DISORDERS

Transcription:

Parenchymal, Interstitial (Restrictive) and Vascular Diseases Alain C. Borczuk, M.D. Dept of Pathology Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar damage pattern (many causes) Goals: To observe the relationship between structural/morphologic manifestation of diseases to measurable functional parameters using prototypical diseases of parenchyma, interstitium and vasculature To describe the pathology, Gross and microscopic, of these pulmonary diseases. Replacement of air with fluid, inflammatory cells Pulmonary Edema Generally, increased hydrostatic pressure due to left sided heart disease Gross Pathology - heavy lungs, wet with frothy fluid. Microscopic - Edema fluid in alveoli spaces, more severe in lower lobes. Disease of the acini and interstitium 1) Replacement of air with fluid, inflammatory cells 2) 3) Destruction of acinar walls Disease of the conducting airways Disease of the pulmonary vasculature Pulmonary Edema Congested, heavy lungs 1

Replacement of air with fluid, inflammatory cells Pneumonia Inflammation of the lung, often infectious Gross Pathology: Consolidation of lungs (firmness), either small patches or lobar Microscopic: Acute bacterial pneumonia, whether lobar or patchy, is characterized by polymorphonuclear cells filling the alveolar spaces. LOBAR Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar damage pattern (many causes) 2

Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar damage pattern (many causes) Hemorrhage Beefy RED Blood filled Replacement of air with fluid, inflammatory cells Hemorrhage Filling of alveolar spaces with blood, often with fibrin. If repeated, hemosiderin deposition reflects the chronic component. Causes: Goodpasture s syndrome Pulmonary vasculitis (Wegener s) Structural lesions with vascular erosion, trauma Replacement of air with fluid, inflammatory cells Pulmonary Edema Pneumonia Hemorrhage Diffuse alveolar damage pattern (many causes) 3

Replacement of air with fluid, inflammatory cells Replacement of air with fluid, inflammatory cells Diffuse alveolar damage Histology of Adult respiratory distress syndrome (ARDS) Many causes include pulmonary infection, shock, sepsis, pancreatitis, burns, toxic inhalations, radiation, near-drowning Acute alveolar injury with microvascular damage leading to edema and tissue injury. Diffuse alveolar damage Gross pathology - firm, airless, heavy and beefy Microscopic - Stages Earliest - edema followed by hyaline membranes - mixtures of cell debris and fibrin (peaks at 2-3 days) Followed by type II pneumocyte hyperplasia (regeneration) Organization - interstitium with fibroblastic proliferation Replacement of air with fluid, inflammatory cells Diffuse alveolar damage Adult Respiratory Distress Syndrome Acute onset of shortness of breath Hypoxemia Bilateral infiltrates on x-ray Non-cardiogenic. 4

Replacement of air with fluid, inflammatory cells Diffuse alveolar damage.bridges diseases of alveolar filling and thickening of interstitium (next section) After the exudative phase, interstitial changes can either resolve or lead to fibrosis (interstitial fibrosis) This acute lung injury is associated with high mortality, especially in the elderly and when associated with sepsis Type II pneumocyte hyperplasia Disease of the acini and interstitium 1) Replacement of air with fluid, inflammatory cells 2) 3) Destruction of acinar walls Disease of the conducting airways Disease of the pulmonary vasculature Replacement of air with fluid, inflammatory cells STRUCTURAL VS. FUNCTIONAL Alveoli filled with blood, neutrophils, hyaline membranes, or fluid Decreased lung volume (atelectasis) Increase in shunt flow In DAD, edema, hypoxic vasoconstriction and vascular injury may cause pulmonary hypertension Idiopathic pulmonary fibrosis/usual interstitial pneumonia Sarcoidosis Hypersensitivity pneumonitis 5

Restrictive lung diseases Interstitium can be thickened by inflammatory cells lymphocytes, histiocytes, granulomas, or fibrosis/fibroblastic proliferation or a combination of both Idiopathic pulmonary fibrosis/usual interstitial pneumonia Sarcoidosis Hypersensitivity pneumonitis Injuries can be associated with diffuse or patchy involvement, and can have varying degrees of cellularity. Cellularity has some prediction of treatment response, although underlying cause/disease is also important. Inflammatory processes are usually steroid responsive Dense fibrosis is irreversible Usual interstitial pneumonia Idiopathic pulmonary process characterized by progressive pulmonary fibrosis Small foci of lung injury lead to fibroblastic proliferation and fibrosis New foci appear alongside normal lung and densely fibrotic lung Mortality is high and disease is resistant to therapy Historical evolution Liebow/Carrington DIP,UIP BIP LIP,GIP Carrington (1978) DIP separate from UIP better prognosis better steroid response Epler/Colby (1985) BOOP 10-20% bilateral/ overlap with UIP on CXR Myers (1987) RBILD Very mild Smoking associated Katzenstein (1994) NSIP Better prognosis Therapy responsive Usual Interstitial Pneumonia Desquamative IP Acute Interstitial Pneumonia Non-specific Interstitial Pneumonia BOOP 6

STRUCTURAL VS. FUNCTIONAL Usual interstitial pneumonia Gross Pathology - Fibrosis involving subpleural areas, leading to honeycomb pattern Microscopic - peripheral lobular fibrosis, dense, with small foci of fibroblastic proliferation; sparing of airways Lung compliance decreased Lung volume decreased Lung recoil increased; airways remain open V/Q mismatch - ventilation unevenly affected. Diffusion reduced, defect elicited by exercise. RESTRICTIVE disease. Historical evolution Liebow/Carrington DIP,UIP BIP LIP,GIP Carrington (1978) Epler/Colby (1985) Myers (1987) Katzenstein (1994) DIP separate from UIP BOOP RBILD NSIP better prognosis 10-20% bilateral/ Very mild Better prognosis better steroid response overlap with UIP on CXR Smoking associated Therapy responsive Usual Interstitial Pneumonia Desquamative IP Acute Interstitial Pneumonia Non-specific Interstitial Pneumonia BOOP 7

Non-specific interstitial pneumonia Katzenstein and Fiorelli (1994) Uniform age of injury and diffuse involvement of lobule. Predominance of chronic inflammatory cells. Vary from cellular to fibrotic Average age (44), associated connective tissue disease, dust exposure, EAA Cellular form, 100% alive at 5 years; worsens with increased fibrosis. Idiopathic pulmonary fibrosis/usual interstitial pneumonia Sarcoidosis Hypersensitivity pneumonitis Sarcoidosis Idiopathic disease characterized by non-necrotizing granulomas in hilar nodes and pulmonary interstitium Can be systemic, and involve skin, eyes/lacrimal glands, and salivary glands (heart, CNS, pituitary also) Remissions can be spontaneous or induced by steroid therapy Most patients recover; some develop respiratory impairment; some progress to end stage fibrosis (10%) Why do we classify? Some patterns are associated with systemic diseases (e.g. NSIP in collagen vascular disease), or fibrosis due to certain medications The idiopathic interstitial pneumonia have different rates of progression to fibrosis Steroid responsiveness is high for some diseases (NSIP,BOOP) and low to non-existent for others (UIP) Mortality rates, likelihood of progression, decision to treat with cytotoxic agent, and candidacy for transplant may all be affected by the classification 8

Idiopathic pulmonary fibrosis/usual interstitial pneumonia Sarcoidosis Hypersensitivity pneumonitis Hypersensitivity pneumonitis (extrinsic allergic alveolitis) Pathology Expansion of peribronchial lymphoid tissue Mild chronic interstitial pneumonitis Interstitial histiocytic collections Hypersensitivity pneumonitis (extrinsic allergic alveolitis) Immunologically mediated (type III/typeIV) lung disease caused by inhalation of organic antigen. Patients have circulating antibodies,complement activation and granuloma formation Named after circumstances surrounding antigen exposure: Pigeon breeder s lung Farmer s lung - thermophilic actinomycetes Humidifier lung - thermophilic bacteria Duck feather fever - duck feather Maple bark disease Mushroom picker s lung Hypersensitivity pneumonitis (extrinsic allergic alveolitis) Patients experience fever, cough, malaise, dyspnea. Acutely, patients may link an exposure with symptoms, but chronic form can be more insidious and therefore detailed history may be needed to make a connection Steroid responsive, but can lead to fibrosis in some patients with untreated chronic antigen exposure 9

In summary: There are a group of restrictive lung diseases characterized by increase in inflammatory cells or fibroblasts in the interstitium/alveolar walls. While they can all lead to fibrosis, some diseases do so invariably (UIP) and others less commonly (NSIP, sarcoid, hypersensitivity). In addition, diseases which are characterized by inflammation are usually steroid responsive. UIP does not respond well to any therapy and therefore has a high mortality. This is why we attempt to classify these diseases by their inflammation and their patterns of fibrosis. Disease of the pulmonary vasculature Pulmonary embolism Pulmonary hypertension Also of note is that fibrosing lung disease can be caused both by idiopathic processes, as well as by certain known processes such as asbestos exposure or collagen vascular disease, for example scleroderma. Some use the term cryptogenic, because even though we know that immunologic reaction can lead to fibrosis, we do not know why some patients with identical exposure or diseases do not develop luing disease Disease of the pulmonary vasculature Pulmonary embolism Pulmonary hypertension Disease of the acini and interstitium 1) Replacement of air with fluid, inflammatory cells 2) 3) Destruction of acinar walls Disease of the conducting airways Disease of the pulmonary vasculature Disease of the pulmonary vasculature Pulmonary embolism Pathology The majority of PE arise from deep venous thrombosis of the lower extremity. Can occlude pulmonary artery at bifurcation (saddle embolus) or pulmonary artery branches Results in infarct only 10% of the time, and infarctions are hemorrhagic when they occur Small emboli organize and recanalize. Chronic PE can lead to pulmonary hypertension 10

11

Disease of the pulmonary vasculature Pulmonary embolism Pulmonary hypertension Disease of the pulmonary vasculature Pulmonary hypertension Gross pathology Pulmonary artery atherosclerosis and dilatation Right ventricular hypertrophy and dilatation, depending on time course of the disease Microscopic pathology Progressive abnormalities reflect severity and duration of hypertension Disease of the pulmonary vasculature Pulmonary hypertension Grading System - Heath and Edwards Grade 1 - hypertrophy of medial smooth muscle Grade 2 - Intimal proliferation Grade 3 - Intimal proliferation with fibrosis and luminal narrowing Grade 4,5 - Complex lesions, with network of capillary like channels, angiomatous and cavernous lesions Grade 6 - Necrosis of vessel wall 12

13